Anju Bhardwaj MD
banner
docbhardwaj.bsky.social
Anju Bhardwaj MD
@docbhardwaj.bsky.social
Advanced HF & Transplant Cardiologist.
Director HFICU @ Memorial Hermann, APD Cards Fellowship @ UT Houston
SoMe Editor #JACCHF;
Associate Editor #JACCAdvances
Section Editor #ASAIO Journal
Reposted by Anju Bhardwaj MD
It's #ISHLT2025 Pre-Conference day! More than 490 medical professionals have come together to dive deeper into #CardiogenicShock, #LungTransplantation, #LungFailure, #CTEPH, and #HealthEquity topics with experts from around the world. 💡🌏
April 26, 2025 at 3:17 PM
📣 The 2023 @accintouch.bsky.social #AHF Staffing Survey is out!

Curious about current staffing trends in #HT #LVAD programs across the U.S.?
Check out the latest data and see how things have evolved over time.

@jaccjournals.bsky.social #JACCHF

👉 www.jacc.org/doi/10.1016/...
The 2023 American College of Cardiology Advanced Heart Failure Staffing Survey: The Report From the ACC Council on Heart Failure and Transplantation
www.jacc.org
April 11, 2025 at 5:21 AM
Reposted by Anju Bhardwaj MD
Do you publish epidemiologic #data on #CVD?

This analysis led by D Abramov & A Mannan demonstrates how different datasets produce different CV death estimates

How data are collected, classified, handled matter

Check out #CDCWONDER vs #GBD #CVD ☠️ estimates 👇🏽

www.ahajournals.org/doi/10.1161/...
April 5, 2025 at 11:04 PM
Reposted by Anju Bhardwaj MD
I am so incredibly grateful to the @accintouch.bsky.social for the honor of being named the 2025 Distinguished Clinical Researcher.

I am blessed to have stood on the shoulders of giants during my career and am thankful to @mgbresearch.bsky.social and #BaimInstitute for support.
April 1, 2025 at 1:37 PM
Reposted by Anju Bhardwaj MD
#DECODECKD trial #ACC25 #LBCT

Assessing DAPA CVD effects in CKD using echo to understand the mechanism of benefit
🫀<1/3 female ❌
🫀LV mass ⬇️ significantly in Dapa arm 🆚 placebo after 6m
🫀no change in LVEF or proBNP or Troponin, UACR but ⬇️eGFR
@accintouch.bsky.social
March 31, 2025 at 3:38 PM
Reposted by Anju Bhardwaj MD
A #JACCAdvances updated network meta-analysis confirms that SAPT remains the safest choice for pts w/out indication for anticoagulation, significantly reducing 🩸 risk w/out 📈 mortality, #cvMI, or stroke risks. Personalized care remains essential. jacc.org/doi/10.1016/... #ACC25 @csilvers.bsky.social
March 31, 2025 at 3:42 PM
Reposted by Anju Bhardwaj MD
ECDP= expert consensus decision pathways presented by @BiykemB #ACC25 @accintouch.bsky.social

EDCPs=how to apply guidelines
CCG= concise clinical guidelines
March 31, 2025 at 4:49 PM
Congratulations @jimjanuzzi.bsky.social
Very well deserved 👏👏
Congratulations @jimjanuzzi.bsky.social on your @accintouch.bsky.social Distinguished Scientist Award!! #ACC25
April 1, 2025 at 3:33 AM
Reposted by Anju Bhardwaj MD
Implantation of an intra-aortic balloon pump (IABP) did not improve 60-day survival or bridge to heart replacement (HRT) therapies in patients w/ HF-CS compared to standard care. #ACC25

Read the journal scan to learn more: bit.ly/4c73BG4 #JACC @jaccjournals.bsky.social

#CardioSky #MedSky
March 30, 2025 at 9:53 PM
Reposted by Anju Bhardwaj MD
Among young athletes, while overall survival after a #SCA is improving, the likelihood of survival varies by race, & SCA is more likely to occur during practice than games, according to a study presented at #ACC25.

More: bit.ly/4l8wIgf

@jaccjournals.bsky.social #SportsCardio #CardioSky #MedSky
March 30, 2025 at 10:32 PM